Pyxis Oncology, Inc. (PYXS)

CIK 1782223 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Pyxis Oncology, Inc..

Recent SEC filings

FiledFormAccession number
Oct 9, 20264/A0000919574-26-006815
Oct 9, 2026SCHEDULE 13G/A0000919574-26-006818
Oct 9, 2026PRE 14A0001193125-26-419208
Oct 5, 2026SCHEDULE 13G0001104659-26-113597
Oct 2, 202640000919574-26-006609
Oct 2, 2026SCHEDULE 13G/A0000919574-26-006608
Oct 1, 20268-K0001437749-26-031767
Oct 1, 2026424B50001437749-26-031667
Sep 29, 2026424B50001437749-26-031470
Sep 29, 2026424B50001437749-26-031480
Sep 9, 20268-K0001193125-26-385901
Sep 8, 20268-K0001193125-26-384386
Sep 8, 202640001193125-26-384391
Aug 28, 2026424B20001193125-26-372221
Aug 27, 2026EFFECT9999999995-26-002786
Aug 20, 202640001193125-26-359525
Aug 20, 2026S-30001193125-26-359246
Aug 14, 202640001193125-26-352206
Aug 13, 20268-K0001193125-26-347911
Aug 13, 202610-Q0001193125-26-347913
Jul 10, 2026SCHEDULE 13G0000921895-26-001796
Jul 10, 202630000919574-26-004386
Jul 2, 20268-K0001193125-26-294613
Jul 2, 2026SCHEDULE 13G/A0000919574-26-004255
Jul 2, 202640001193125-26-294708